← Leaderboards
Kelli Lea Palmer
Massachusetts Eye And Ear Infirmary
$5,061,902
Attributed
$8,076,387
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,076,387 · 8
By mechanism
R01$6,351,496 · 3
R21$893,550 · 2
R56$478,792 · 1
K22$264,486 · 1
F32$88,063 · 1
Top collaborators
- Ziqiang Guan9 shared
- Kelly S Doran3 shared
- Julian G Hurdle2 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPathogenBacteriaAntibioticsStructureAntimicrobialAntibiotic ResistanceGeneticResistanceMolecularPathway InteractionsEnterococcusInfectionVirulenceAnabolismBiological Adaptation To StressPhylogenetic AnalysisLipidsOrganismGrowthIn VitroLipoteichoic AcidBiochemicalCharge
Grant awards (22)
Roles of novel cationic lipids in bacterial pathogenesis$649,409
R01 · FY2025 · AI · contact PI
Roles of novel cationic lipids in bacterial pathogenesis$649,409
R01 · FY2024 · AI · contact PI
Adaptive alterations of lipids in mitis group streptococci$515,054
R01 · FY2024 · AI · contact PI
Roles of novel cationic lipids in bacterial pathogenesis$672,729
R01 · FY2023 · AI · contact PI
Adaptive alterations of lipids in mitis group streptococci$515,054
R01 · FY2023 · AI · contact PI
Mechanism Of Enterococcus Faecalis Nitro Drug Metabolism And In Vivo Implications$232,000
R21 · FY2023 · AI · contact PI
Adaptive alterations of lipids in mitis group streptococci$474,697
R01 · FY2022 · AI · contact PI
Mechanism Of Enterococcus Faecalis Nitro Drug Metabolism And In Vivo Implications$222,000
R21 · FY2022 · AI · contact PI
Adaptive alterations of lipids in mitis group streptococci$474,697
R01 · FY2021 · AI · contact PI
Adaptive alterations of lipids in mitis group streptococci$487,947
R01 · FY2020 · AI · contact PI
Adaptive Alterations of Lipids in Streptococcus Mitis$478,792
R56 · FY2019 · AI · contact PI
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium$382,500
R01 · FY2019 · AI · contact PI
Genetic basis for virulence in Streptococcus mitis and S. oralis$191,993
R21 · FY2019 · AI · contact PI
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium$382,500
R01 · FY2018 · AI · contact PI
Genetic basis for virulence in Streptococcus mitis and S. oralis$247,557
R21 · FY2018 · AI · contact PI
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium$382,500
R01 · FY2017 · AI · contact PI
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium$382,500
R01 · FY2016 · AI · contact PI
Genome defense and acquired antibiotic resistance in Enterococcus faecalis and Enterococcus faecium$382,500
R01 · FY2015 · AI · contact PI
CRISPR defense and acquired antibiotic resistance in Enterococcus faecalis$107,776
K22 · FY2014 · AI · contact PI
CRISPR defense and acquired antibiotic resistance in Enterococcus faecalis$156,710
K22 · FY2013 · AI · contact PI
Novel Strategy for Endophthalmitis Drug Targets$40,457
F32 · FY2011 · EY · contact PI
Novel Strategy for Endophthalmitis Drug Targets$47,606
F32 · FY2010 · EY · contact PI